Development of a conditional bioluminescent transplant model for TPM3-ALK-induced tumorigenesis as a tool to validate ALK-dependent cancer targeted therapy.
第一作者:
Sylvie,Giuriato
第一单位:
INSERM, U563, Centre de Physiopathologie de Toulouse Purpan, Toulouse, France. giuriato@toulouse.inserm.fr
作者:
主题词
动物(Animals);抗生素类, 抗肿瘤(Antibiotics, Antineoplastic);苯醌类(Benzoquinones);细胞转化, 肿瘤(Cell Transformation, Neoplastic);疾病模型, 动物(Disease Models, Animal);药物筛选试验, 抗肿瘤(Drug Screening Assays, Antitumor);基因, 报告(Genes, Reporter);内酰胺类, 大环(Lactams, Macrocyclic);萤光素酶类(Luciferases);发光物质(Luminescent Agents);淋巴瘤, 大细胞, 间变性(Lymphoma, Large-Cell, Anaplastic);小鼠(Mice);小鼠, 裸(Mice, Nude);肿瘤移植(Neoplasm Transplantation);癌基因蛋白质类, 融合(Oncogene Proteins, Fusion);蛋白激酶抑制剂(Protein Kinase Inhibitors);蛋白酪氨酸激酶类(Protein-Tyrosine Kinases);受体蛋白质酪氨酸激酶类(Receptor Protein-Tyrosine Kinases);利福布丁(Rifabutin);原肌球蛋白(Tropomyosin)
DOI
10.4161/cbt.6.8.4508
PMID
17660712
发布时间
2022-03-31
- 浏览5

Cancer biology & therapy
1318-23页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文